NCT00665145View on ClinicalTrials.gov

Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy
Interventions
DRUG

SB-509

Active drug

DRUG

SB-509

Active drug

DRUG

Placebo

Placebo

DRUG

SB-509

Active drug

Trial Locations (4)

77030

Houston

78229

San Antonio

92037

La Jolla

94598

Walnut Creek

Sponsors
All Listed Sponsors
lead

Sangamo Therapeutics

INDUSTRY